4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride 98%

cute Research centre (ARC) is a full service provider in basic chemistry research, API development of first to file (FTF) & future generics molecules, cost effective commercial technology of existing API and Intermediates, CRAMS, synthesis and characterization of analytical standards/impurities and regulatory expertise for global markets along with cGMP support services.The API development team focuses on novel chemistry including novel polymorph and process to provide our customers with possible early entry opportunities in various markets with help of our IP expertise.Expertise in the developments of cost effective novel technologies of API / Intermediates free from Genotoxtic impurities and quality benchmarking in identical with innovators. Our experience of more than 35 yrs with patents and several publications worldwide. ARC team brings a depth knowledge and breadth of experience across drug substance/product development pathways, allowing us to address the full scope of a client’s regulatory and drug substance development needs and closely worked with various regulatory authorities.